Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Antiangiogenic therapy in Sorsby's fundus dystrophy without a mutation in the TIMP-3 gene].

Archivos de la Sociedad Espanola de Oftalmologia - 1 Jun 2013

Copete-Piqueras S, Cava-Valenciano C, Flores-Moreno I, Moreno-Valladares A, Bautista Ruescas V

Abstract excerpt

CASE REPORT: The case is presented of a 32-year-old man referring to metamorphopsia and blurred vision in both eyes for 3 days. Best corrected visual acuity of 20/32 in the right eye and 20/25 in the left eye. Fundus examination revealed the presence of drusen-like deposits, suggestive of Sorsby'...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiogenesis Inhibitors
Share to Antibodies, Monoclonal, Humanized
Share to Macular Degeneration

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Tissue Inhibitor of Metalloproteinase-3

Source

Identifiers

PMID: 23726310
DOI: 10.1016/j.oftal.2011.12.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23726310-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Antiangiogenic therapy in Sorsby's fundus dystrophy without a mutation in the TIMP-3 gene].PMID 23726310Read ↗

Sorsby fundus dystrophy (SFD): A narrative review.Semantic proximity Read ↗

Sorsby fundus dystrophy: Insights from the past and looking to the future.Semantic proximity Read ↗

TIMP3 mutation in Sorsby's fundus dystrophy: molecular insights.Semantic proximity Read ↗

A novel mutation at the N-terminal domain of the TIMP3 gene in Sorsby fundus dystrophy.Semantic proximity Read ↗

Clinical features of a novel TIMP-3 mutation causing Sorsby's fundus dystrophy: implications for disease mechanism.Semantic proximity Read ↗

Review: Mechanisms of TIMP-3 accumulation and pathogenesis in Sorsby fundus dystrophy.Semantic proximity Read ↗

Sorsby Fundus Dystrophy: Novel Mutations, Novel Phenotypic Characteristics, and Treatment Outcomes.Semantic proximity Read ↗

Sorsby fundus dystrophy without a mutation in the TIMP-3 gene.Semantic proximity Read ↗

Sorsby Fundus Dystrophy Mutation in Tissue Inhibitor of Metalloproteinase 3 (TIMP3) promotes Choroidal Neovascularization via a Fibroblast Growth Factor-dependent Mechanism.Semantic proximity Read ↗

A novel Ser156Cys mutation in the tissue inhibitor of metalloproteinases-3 (TIMP3) in Sorsby's fundus dystrophy with unusual clinical features.Semantic proximity Read ↗

Sorsby's fundus dystrophy in two Japanese families with unusual clinical features.Semantic proximity Read ↗

A novel splice site mutation in the tissue inhibitor of the metalloproteinases-3 gene in Sorsby's fundus dystrophy with unusual clinical features.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.